Search Results - "Daud, N.A."

Prevalence of IHD among different age brackets in patients with uncontrolled type 2 diabetes mellitus by Shaharuddin, S., Thuraisingam, S., Daud, N.A., Shafie, S.D., Hashim, R., Zulkifly, H.H.

Get full text

Nutritional status, hemoglobin and total lymphocyte count factors readmission in head and neck cancer patients by Daud, N.A., Madjid, M., Rahardjo, F.

Get full text

P-Glycoprotein-Mediated Drug Interactions in Pregnancy and Changes in the Risk of Congenital Anomalies: A Case-Reference Study by Daud, Aizati N. A., Bergman, Jorieke E. H., Bakker, Marian K., Wang, Hao, Kerstjens-Frederikse, Wilhelmina S., de Walle, Hermien E. K., Groen, Henk, Bos, Jens H. J., Hak, Eelko, Wilffert, Bob

“…Introduction Drug use in pregnancy is very common but may cause harm to the fetus. The teratogenic effect of a drug is partly dependent on the drug level in…”
Get full text

Maternal use of drug substrates of placental transporters and the effect of transporter-mediated drug interactions on the risk of congenital anomalies by Daud, Aizati N A, Bergman, Jorieke E H, Oktora, Monika P, Kerstjens-Frederikse, Wilhelmina S, Groen, Henk, Bos, Jens H, Hak, Eelko, Wilffert, Bob

“…A number of transporter proteins are expressed in the placenta, and they facilitate the placental transfer of drugs. The inhibition of P-glycoprotein (P-gp)…”
Get full text

The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors-Is Pharmacogenetics the Key? by Daud, Aizati N A, Bergman, Jorieke E H, Kerstjens-Frederikse, Wilhelmina S, Groen, Henk, Wilffert, Bob

“…Serotonin reuptake inhibitors (SRIs) are often prescribed during pregnancy. Previous studies that found an increased risk of congenital anomalies, particularly…”
Get full text

Prenatal exposure to serotonin reuptake inhibitors and congenital heart anomalies: an exploratory pharmacogenetics study by Daud, Aizati N A, Bergman, Jorieke E H, Kerstjens-Frederikse, Wilhelmina S, van der Vlies, Pieter, Hak, Eelko, Berger, Rolf M F, Groen, Henk, Wilffert, Bob

“…To explore the role of pharmacogenetics in determining the risk of congenital heart anomalies (CHA) with prenatal use of serotonin reuptake inhibitors. We…”
Get full text

Knowledge and attitude regarding pharmacogenetics among formerly pregnant women in the Netherlands and their interest in pharmacogenetic research by Daud, Aizati N A, Bergsma, Eefke L, Bergman, Jorieke E H, De Walle, Hermien E K, Kerstjens-Frederikse, Wilhelmina S, Bijker, Bert J, Hak, Eelko, Wilffert, Bob

“…Pharmacogenetics is an emerging field currently being implemented to improve safety when prescribing drugs. While many women who take drugs during pregnancy…”
Get full text

Pharmacogenetics of drug-induced birth defects: the role of polymorphisms of placental transporter proteins by Daud, Aizati N A, Bergman, Jorieke E H, Bakker, Marian K, Wang, Hao, de Walle, Hermien E K, Plösch, Torsten, Wilffert, Bob

“…One of the ongoing issues in perinatal medicine is the risk of birth defects associated with maternal drug use. The teratogenic effect of a drug depends, apart…”
Get more information